Keesha L. Powell-Roach

Dr. Keesha L. Powell-Roach

University of Florida, College of Nursing
orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
EAEdwin Aroke
Edwin Aroke
KPKeesha L. Powell-Roach
Keesha L. Powell-Roach
RJROSARIO JAIME-LARA
ROSARIO JAIME-LARA
MWMarkos Tesfaye Woldeyohannes
Markos Tesfaye Woldeyohannes
ARAbhrarup Roy
Abhrarup Roy
Paule Valery JosephPaule Valery Joseph
Paule Valery Joseph
Transient receptor potential (TRP) channels are a superfamily of cation transmembrane proteins that are expressed in many tissues and respond to many sensory stimuli. TRP channels play a role in sensory signaling for taste, thermosensation, mechanosensation, and nociception. Activation of TRP channels (e.g., TRPM5) in taste receptors by food/chemicals (e.g., capsaicin) is essential in the acquisition of nutrients, which fuel metabolism, growth, and development. Pain signals from these nociceptors are essential for harm avoidance. Dysfunctional TRP channels have been associated with neuropathic pain, inflammation, and reduced ability to detect taste stimuli. Humans have long recognized the relationship between taste and pain. However, the mechanisms and relationship among these taste–pain sensorial experiences are not fully understood. This article provides a narrative review of literature examining the role of TRP channels on taste and pain perception. Genomic variability in the TRPV1 gene has been associated with alterations in various pain conditions. Moreover, polymorphisms of the TRPV1 gene have been associated with alterations in salty taste sensitivity and salt preference. Studies of genetic variations in TRP genes or modulation of TRP pathways may increase our understanding of the shared biological mediators of pain and taste, leading to therapeutic interventions to treat many diseases.

1 September 2019 in Experimental Gerontology
Verified
Journal Article
Closed access
SBStaja Booker
Staja Booker
JCJosue Cardoso
Josue Cardoso
YCYenisel Cruz-Almeida
Yenisel Cruz-Almeida
KSKimberly T. Sibille
Kimberly T. Sibille
ETEllen L. Terry
Ellen L. Terry
RFRoger B Fillingim
Roger B Fillingim

15 July 2020 in Biological Research For Nursing
Verified
Journal Article
Closed access
PDF file
EAEdwin Aroke
Edwin Aroke
KPKeesha L. Powell-Roach
Keesha L. Powell-Roach
Chronic pain is a significant public health problem in the United States, affecting approximately 100 million people. Yet there is a lack of robust biomarkers for clinical use in chronic pain conditions. Downstream effects of environmental, genomic, and proteomic variations in individuals with chronic pain conditions can be identified and quantified using a metabolomic approach. The purpose of this systematic review was to examine the literature for reports of potential metabolomic signatures associated with chronic pain conditions. We searched relevant electronic databases for published studies that used various metabolomic approaches to investigate chronic pain conditions among subjects of all ages. Our search identified a total of 586 articles, 18 of which are included in this review. The reviewed studies used metabolomics to investigate fibromyalgia (n = 5), osteoarthritis (n = 4), migraine (n = 3), musculoskeletal pain (n = 2), and other chronic pain conditions (n = 1/condition). Results show that several known and newly identified metabolites differ in individuals with chronic pain conditions compared to those without these conditions. These include amino acids (e.g., glutamine, serine, and phenylalanine) and intermediate products (e.g., succinate, citrate, acetylcarnitine, and N-acetylornithine) of pathways that metabolize various macromolecules. Though more high-quality research is needed, this review provides insights into potential biomarkers for future metabolomics studies in people with chronic pain conditions.

1 January 2022 in The Journal of Pain
Verified
Journal Article
Closed access
MPMonika Patel
Monika Patel
AJAlisa J. Johnson
Alisa J. Johnson
SBStaja Q. Booker
Staja Q. Booker
EBEmily J. Bartley
Emily J. Bartley
SPShreela Palit
Shreela Palit
KSKimberly T. Sibille
Kimberly T. Sibille

5 January 2021 in Pain Management Nursing
Verified
Journal Article
Open access
JCJanet H. Van Cleave
Janet H. Van Cleave
SBStaja Q. Booker
Staja Q. Booker
KPKeesha L. Powell-Roach
Keesha L. Powell-Roach
ELEva Liang
Eva Liang
JKJennifer Kawi
Jennifer Kawi
Nursing brings a unique lens to care of patients with pain and opioid misuse. This scoping review describes nursing's contribution to the literature on the management of patients with pain and opioid misuse, generating evidence to guide clinical care. The scoping review was conducted according to Preferred Reporting Items for Systematic Review and Meta-Analyses extension for Scoping Reviews guideline. Using combined key terms ("opioid misuse," "pain," "nursing") in systematic searches in PubMed and Cumulative Index to Nursing and Allied Health Literature (CINAHL) electronic databases, snowball technique, and personal knowledge resulted in 108 relevant articles, reports, and websites. Summative approach to content analysis was used to quantify and describe nursing's contribution to the literature. Contributions of nurses emerged in the areas of research, clinical practice, policy, and education. The highest number of publications addressed research (50%, 54 of 108), whereas the fewest number of publications involved education (7%, 8 of 108). Results provide a picture of the breadth of expertise and crucial leadership that nurses contribute to influence management of patients with pain and opioid misuse. This scoping review indicates the importance of continued support from key stakeholders, including training and interprofessional collaboration opportunities supported by the National Institutes of Health, to sustain nursing's contribution to quality care of patients with pain and opioid misuse. Ultimately, all health care professionals must collaborate to conduct rigorous research and construct evidence-based guidelines to inform policy initiatives and education strategies to solve the complex co-occurring epidemics of pain and opioid misuse.

1 March 2019 in Pain Reports
Verified
Journal Article
Open access
JSJudith Michelle Schlaeger
Judith Michelle Schlaeger
CPCrystal L. Patil
Crystal L. Patil
ASAlana D. Steffen
Alana D. Steffen
HPHeather A. Pauls
Heather A. Pauls
KPKeesha L. Powell-Roach
Keesha L. Powell-Roach
DWDiana J. Wilkie
Diana J. Wilkie
Objectives: To evaluate self-reported sensory pain scores of women with generalized vulvodynia (GV) and provoked vestibulodynia (PVD), characterize pain phenotypes, and assess feasibility of using the Internet for recruitment and data collection among women with vulvodynia. Methods: Descriptive online survey. Data collected using an online survey accessed via a link on the National Vulvodynia Association web site. Convenience sample, 60 women aged 18 to 45 years (mean = 32.7 ± 5.5); 50 white, 2 black/African American, 4 Hispanic/Latino, and 4 Native American/Alaskan Native, diagnosed with vulvodynia, not in menopause. Pain assessment and medication modules from PAINReportlt. Results: Women with GV (n = 35) compared to PVD (n = 25). Estimated mean pain sites (2.5 ± 1.4 vs 2.2 ± 1.0, P = 0.31), mean current pain (8.7 ± 1.4 vs 5.5 ± 4.0, P = 0.0008), worst pain (8.1 ± 1.8 vs 6.1 ± 3.6, P = 0.02), and least pain in the past 24 hours (4.4 ± 1.8 vs 2.0 ± 2.0, P < 0.0001). Average pain intensity (7.1 ± 1.2 vs 4.6 ± 2.9, P = 0.0003) on a scale of 0 to 10, mean number of neuropathic words (8.3 ± 3.6 vs 7.7 ± 5.0), and mean number of nociceptive words (6.9 ± 4 vs 7.5 ± 4.4). Nineteen (54%) women with GV compared to 9 (38%) with PVD were not satisfied with pain levels. Conclusion: Women with GV reported severe pain, whereas those with PVD reported moderate to severe pain. Pain quality descriptors may aid a clinician's decisions about whether to prescribe adjuvant drugs vs opioids to women with vulvodynia.